Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Peripheral Vascular Stents Market, by Mode of Delivery
1.4.2 Europe Peripheral Vascular Stents Market, by End-use
1.4.3 Europe Peripheral Vascular Stents Market, by Product
1.4.4 Europe Peripheral Vascular Stents Market, by Stents Type
1.4.5 Europe Peripheral Vascular Stents Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies developed in Peripheral Vascular Stents Market
Chapter 5. Europe Peripheral Vascular Stents Market by Mode of Delivery
5.1 Europe Balloon-expandable Stents Market by Country
5.2 Europe Self-expanding Stents Market by Country
Chapter 6. Europe Peripheral Vascular Stents Market by End-use
6.1 Europe Hospitals & Cardiac Centers Market by Country
6.2 Europe Ambulatory Surgical Centers Market by Country
6.3 Europe Others Market by Country
Chapter 7. Europe Peripheral Vascular Stents Market by Product
7.1 Europe Iliac Artery Stents Market by Country
7.2 Europe Femoral Artery Stents Market by Country
7.3 Europe Carotid Artery Stents Market by Country
7.4 Europe Renal Artery Stents Market by Country
7.5 Europe Others Market by Country
Chapter 8. Europe Peripheral Vascular Stents Market by Stents Type
8.1 Europe Drug Eluting Stents (DES) Market by Country
8.2 Europe Bare Metal Stents (BMS) Market by Country
8.3 Europe Bioabsorbable Stents Market by Country
Chapter 9. Europe Peripheral Vascular Stents Market by Country
9.1 Germany Peripheral Vascular Stents Market
9.1.1 Germany Peripheral Vascular Stents Market by Mode of Delivery
9.1.2 Germany Peripheral Vascular Stents Market by End-use
9.1.3 Germany Peripheral Vascular Stents Market by Product
9.1.4 Germany Peripheral Vascular Stents Market by Stents Type
9.2 UK Peripheral Vascular Stents Market
9.2.1 UK Peripheral Vascular Stents Market by Mode of Delivery
9.2.2 UK Peripheral Vascular Stents Market by End-use
9.2.3 UK Peripheral Vascular Stents Market by Product
9.2.4 UK Peripheral Vascular Stents Market by Stents Type
9.3 France Peripheral Vascular Stents Market
9.3.1 France Peripheral Vascular Stents Market by Mode of Delivery
9.3.2 France Peripheral Vascular Stents Market by End-use
9.3.3 France Peripheral Vascular Stents Market by Product
9.3.4 France Peripheral Vascular Stents Market by Stents Type
9.4 Russia Peripheral Vascular Stents Market
9.4.1 Russia Peripheral Vascular Stents Market by Mode of Delivery
9.4.2 Russia Peripheral Vascular Stents Market by End-use
9.4.3 Russia Peripheral Vascular Stents Market by Product
9.4.4 Russia Peripheral Vascular Stents Market by Stents Type
9.5 Spain Peripheral Vascular Stents Market
9.5.1 Spain Peripheral Vascular Stents Market by Mode of Delivery
9.5.2 Spain Peripheral Vascular Stents Market by End-use
9.5.3 Spain Peripheral Vascular Stents Market by Product
9.5.4 Spain Peripheral Vascular Stents Market by Stents Type
9.6 Italy Peripheral Vascular Stents Market
9.6.1 Italy Peripheral Vascular Stents Market by Mode of Delivery
9.6.2 Italy Peripheral Vascular Stents Market by End-use
9.6.3 Italy Peripheral Vascular Stents Market by Product
9.6.4 Italy Peripheral Vascular Stents Market by Stents Type
9.7 Rest of Europe Peripheral Vascular Stents Market
9.7.1 Rest of Europe Peripheral Vascular Stents Market by Mode of Delivery
9.7.2 Rest of Europe Peripheral Vascular Stents Market by End-use
9.7.3 Rest of Europe Peripheral Vascular Stents Market by Product
9.7.4 Rest of Europe Peripheral Vascular Stents Market by Stents Type
Chapter 10. Company Profiles
10.1 Boston Scientific Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Terumo Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.5.3 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 Abbott Laboratories
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Biotronik SE & Co. KG
10.5.1 Company Overview
10.5.2 SWOT Analysis
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Cook Medical, Inc. (Cook Group)
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 MicroPort Scientific Corporation
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 LifeTech Scientific Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 SWOT Analysis
10.10. iVascular S.L.U.
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Product Launches and Product Expansions:
10.10.3 SWOT Analysis
Unique Offerings 